MAP Pharmaceuticals (MAPP)
$9.17
-0.06 (-0.65%)
| CAPS Rating |
|
|---|---|
| Open | $9.19 |
| Previous Close | $9.23 |
| Daily Range | $8.98 - $9.21 |
| 52-Week Range | $1.57 - $13.85 |
| Market Cap | $224.62M |
| P/E Ratio | 0.09 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 98,274 |
| Average Daily Volume | 77,000 |
MAPP
VS S&P 500 (SPY)
How do you think MAPP will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MAPP Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MAPP News and Commentary
- 3 Stocks Ready to Roar – The Motley Fool
- 9 Stocks to Shake the Market – The Motley Fool
- These 5 Underdogs Are No Dogs – The Motley Fool
Related News and Articles
- A Big Upgrade for Amylin Pharmaceuticals – The Motley Fool
- Build Your Fortune With These Winners – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 12 Companies With Ironclad Balance Sheets – The Motley Fool
- 7 Dividend Divas – The Motley Fool
- A Schizophrenic Move by Merck? – The Motley Fool
- Do Good Without Being a Corporate Hotshot – The Motley Fool
- 52-Week Highs! What's Going On? – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- The Side Effect of Developing Obesity Drugs – The Motley Fool
- How I'm Grabbing 20% Dividend Yields – The Motley Fool
- Are These Dividends Too Good to Be True? – The Motley Fool
- This Baby Is a Nice Addition – The Motley Fool
- Now Is the Time to Buy Risk – The Motley Fool
RSS Headlines
Fool UK
